Stefan Schumacher Tour de France 2008

The German Cycling Federation (BDR) has confirmed reports that Stefan Schumacher tested positive for banned blood-boosting drug CERA at this year's Tour de France.

Schumacher failed two retrospective blood tests carried out by the French anti-doping agency AFLD for blood-boosting drug Continuous Erythropoiesis Receptor Activator (CERA), a new form of EPO.

One sample was taken on July 3, just prior to this year?s Tour de France, and the other was taken during the event on July 15, where Schumacher won both time trial stages and wore the yellow leader?s jersey.

The BDR has now given Schumacher five days to request that his B samples are tested if he so wishes. Either way, the 27-year-old former Gerolsteiner rider is looking at the maximum two-year ban from competition and his cycling career is over.


Comment: Why more EPO positives are good for cycling

Stefan Schumacher tests positive at Tour de France

IOC official wants cycling dropped from Olympics

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.